Zobrazeno 1 - 10
of 100
pro vyhledávání: '"Anupma Nayak"'
Autor:
Jennifer B. Shah, Dana Pueschl, Bradley Wubbenhorst, Mengyao Fan, John Pluta, Kurt D’Andrea, Anna P. Hubert, Jake S. Shilan, Wenting Zhou, Adam A. Kraya, Alba Llop Guevara, Catherine Ruan, Violeta Serra, Judith Balmaña, Michael Feldman, Pat J. Morin, Anupma Nayak, Kara N. Maxwell, Susan M. Domchek, Katherine L. Nathanson
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-19 (2022)
Carriers of pathogenic BRCA1/2 variants have a higher risk of breast and ovarian cancers, which recur frequently. Here, the authors sequence primary and recurrent tumours of BRCA1/2 mutation carriers, finding PARP1 amplifications, differential BRCA2
Externí odkaz:
https://doaj.org/article/86e2b8acb27543e9aad8ac4d1b5b8463
Autor:
Emily J. Gallagher, Kezhen Fei, Sheldon M. Feldman, Elisa Port, Neil B. Friedman, Susan K. Boolbol, Brigid Killelea, Melissa Pilewskie, Lydia Choi, Tari King, Anupma Nayak, Rebeca Franco, Daliz Cruz, Irini M. Antoniou, Derek LeRoith, Nina A. Bickell
Publikováno v:
Breast Cancer Research, Vol 22, Iss 1, Pp 1-10 (2020)
Abstract Background Racial disparities in breast cancer survival between Black and White women persist across all stages of breast cancer. The metabolic syndrome (MetS) of insulin resistance disproportionately affects more Black than White women. It
Externí odkaz:
https://doaj.org/article/dbb802256d2542bdaa3a9fa52e21db53
Publikováno v:
International Journal of Breast Cancer, Vol 2017 (2017)
Oncotype Dx is used to determine the recurrence risk (RR) in patients with estrogen receptor positive (ER+) and lymph node negative (LN−) breast cancer. The RR is divided into low (0–17), intermediate (18–30), and high (31) to predict chemother
Externí odkaz:
https://doaj.org/article/c5efee5ef7d94381b7ae2a792621251c
Autor:
Ajeya Nandi, Rahul Debnath, Anupma Nayak, Tsun Ki Jerrick To, Gatha Thacker, Megan Reilly, Sanjeev Gumber, Ilias Karagounis, Ning Li, Christopher J. Lengner, Malay Haldar, Alana L. Welm, Andres M. Blanco, Christoforos Thomas, Rumela Chakrabarti
Publikováno v:
Cancer Res
Resistance to radiotherapy is a major obstacle for effective cancer treatment. Both cancer-associated fibroblasts (CAF) within the tumor microenvironment (TME) and Notch signaling are implicated in radioresistance, but their potential interrelationsh
Autor:
Qing Chen, Zachary T. Schug, Ashani T. Weeraratna, Maureen E. Murphy, Meenhard Herlyn, Xiaowei Xu, Anupma Nayak, Pulak Ray, Ezra Baraban, Joshua L.D. Parris, Gretchen M. Alicea, Ke Xu, Caroline E. Perry, Nan Cheng, Andrea Watters, Yongkang Zou
Figure S2 shows astrocytes facilitate the growth and survival of brain metastatic cancer cells.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52297e2b533e08a945df81a22f14d220
https://doi.org/10.1158/2159-8290.22535935.v1
https://doi.org/10.1158/2159-8290.22535935.v1
Autor:
Qing Chen, Zachary T. Schug, Ashani T. Weeraratna, Maureen E. Murphy, Meenhard Herlyn, Xiaowei Xu, Anupma Nayak, Pulak Ray, Ezra Baraban, Joshua L.D. Parris, Gretchen M. Alicea, Ke Xu, Caroline E. Perry, Nan Cheng, Andrea Watters, Yongkang Zou
Brain metastasis, the most lethal form of melanoma and carcinoma, is the consequence of favorable interactions between the invading cancer cells and the brain cells. Peroxisome proliferator–activated receptor γ (PPARγ) has ambiguous functions in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d03e40db34df019d18670ce64492bb5f
https://doi.org/10.1158/2159-8290.c.6547984.v1
https://doi.org/10.1158/2159-8290.c.6547984.v1
Autor:
Katherine L. Nathanson, Robert H. Vonderheide, Susan M. Domchek, Anupma Nayak, Michael Feldman, Jennifer J.D. Morrissette, Nandita Mitra, Amanda Barrett, Nicole Lunceford, Liza M. Dorfman, Andrew J. Rech, John Pluta, Brandon M. Wenz, Bradley Wubbenhorst, Kara N. Maxwell, Adam A. Kraya
Supplementary Figures S1-S4, Tables S4, S6.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::742de8fb763cbbc859afff863f907911
https://doi.org/10.1158/1078-0432.22471266
https://doi.org/10.1158/1078-0432.22471266
Supplementary method
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e144e165473b5e37ba3b5db1fde1788
https://doi.org/10.1158/0008-5472.22411433.v1
https://doi.org/10.1158/0008-5472.22411433.v1
Patients with triple-negative breast cancers (TNBC) are at high risk for recurrent or metastatic disease despite standard treatment, underscoring the need for novel therapeutic targets and strategies. Here we report that protein tyrosine kinase 6 (PT
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d8ac0ad616b459ab4a655b813760cc09
https://doi.org/10.1158/0008-5472.c.6508223.v1
https://doi.org/10.1158/0008-5472.c.6508223.v1
Autor:
Katherine L. Nathanson, Robert H. Vonderheide, Susan M. Domchek, Anupma Nayak, Michael Feldman, Jennifer J.D. Morrissette, Nandita Mitra, Amanda Barrett, Nicole Lunceford, Liza M. Dorfman, Andrew J. Rech, John Pluta, Brandon M. Wenz, Bradley Wubbenhorst, Kara N. Maxwell, Adam A. Kraya
Characteristics of breast cancers ascertained from Penn Medicine hospitals
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29b7d87e54549c0eddc947172cdbb861
https://doi.org/10.1158/1078-0432.22471260.v1
https://doi.org/10.1158/1078-0432.22471260.v1